CIK 0001626878 · Non-accelerated filer<br>Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Executive Officer sold 89,286 shares at an average $12.67 ($1,131,099)
- 4 Open-market sale Chief Executive Officer sold 48,613 shares at an average $12.84 ($624,181)
- 4 Open-market sale Chief Executive Officer sold 60,901 shares at an average $13.34 ($812,117)
- 4 Open-market sale Chief Executive Officer sold 51,200 shares at an average $14.72 ($753,419)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $15.15 ($757,584)
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at $18.15 ($907,350)
- 4 Option exercise Director acquired 25,000 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 6 of 21 · 408 filings